Phase 2 proof-of-concept double-blind, randomized, placebo-controlled, multiple dose study of CPL280 in Type 2 Diabetes

Status: Planning

Phase of Trial: Phase II

Latest Information Update: 07 Jul 2021

Price : $35 ^*

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

30 Jun 2021 According to a Celon Pharma media release, the company has announced filing for approval to initiate this study.
22 Jun 2021 According to a Celon Pharma media release, the first patient is expected to be dosed in Q4 2021 and top-line results are anticipated in 1H 2022.
22 Jun 2021 According to a Celon Pharma media release, the company announced filing for approval to start this Phase II clinical study of CPL280,in type 2 diabetes.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com